Objectives {7}
SECONDARY
The primary objective of this trial is to evaluate the efficacy of the PECS II block in patients undergoing unilateral MICS expressed as the reduction in the overall opioid demand given as intravenous MME during the first 24 h after extubation.The secondary objective of this trial is to evaluate the effect of the PECS II block in patients undergoing unilateral MICS on the interval until extubation, ICU discharge, data on ICU, length of hospital stay (LOS), the visual analog scale (VAS) at 2, 4, 6, 12, and 24 h after extubation, and the Overall Benefit of Analgesia Score (OBAS) at 24 h after extubation [